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458to <10.0%, and $10.0%). The relationship between
HbA1c group and study outcomes were evaluated
using multivariable Cox Proportional Hazard regres-
sion, adjusting for all baseline covariates. The statis-
tical procedures were repeated using updated HbA1c
as a time-updated analysis.
After a median follow-up of 54.5 to 58.5 months,
amongst the 10 HbA1c groups, unadjusted incidence
rates for CVD events and all-cause mortality were 13.8
to 28.8 and 9.4 to 32.3 per 1,000 person-years,
respectively. A J-shaped curvilinear relationship was
identiﬁed between HbA1c levels and CVD incidence,
all-cause mortality, as well as other outcomes
(Figure 1). An HbA1c range of $7.0% to <7.5% had the
lowest risk of new CVD, CHD, stroke, heart failure, all-
cause mortality, and CVD-related mortality. When
compared to a HbA1c range of $7.0% to <7.5%,
HbA1c <6.5% or $8.0% was associated with a signif-
icantly higher incidence of CVD and all-cause
mortality. Similar results were obtained in the time-
updated analysis.
This study had several limitations. This was a
retrospective cohort study, which is lower in terms of
evidence hierarchy than a randomized controlled
trial. Drug exposure over time and life-style behavior
risk factors such as diet and exercise were not taken
into account in the analyses. This study was under-
taken in Hong Kong, and the pattern of association
between HbA1c and outcomes may differ in other
Chinese populations. The relationship may be subject
to temporal changes and modiﬁcations in unmea-
sured risk factors or interventions.
The results of this territory-wide, naturalistic,
cohort study of Chinese primary care patients with
T2DM supports the ﬁndings of previous observational
studies conducted in the United States, United
Kingdom, Denmark, and the Netherlands, demon-
strating a J-shaped pattern of association between
HbA1c and CVD and all-cause mortality (1). Similar J-
shaped relationships were also identiﬁed for CHD,
stroke, heart failure, and CVD-related mortality.
Although this phenomenon has been postulated to
be related to the deleterious effects of severe hypo-
glycemia (3), this is controversial, and it remains
unclear why low levels of HbA1c are associated with
a higher risk of CVD and all-cause mortality.*Eric Yuk Fai Wan, MSc, CStat
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by Coronary Computed
Tomography Angiography
and Association With
Acute Coronary SyndromeThe study by Motoyama et al. (1) expands on their
previous excellent sentinel work (2). The authors
showed that in 3,158 patients with a mean follow up
of 3.4  2.4 years, computed tomography angiog-
raphy (CTA)-veriﬁed high-risk plaque (HRP) was an
independent predictor of acute coronary syndrome
(ACS). In addition, in a subgroup of 449 patients
who underwent serial CTA, plaque progression was
an independent predictor of ACS.
The authors deﬁned HRP on the basis of 2 high-risk
features, positive remodeling (remodeling index $1.1)
and low-attenuation plaque (<30 HU). It would have
been of interest whether the addition of other less
sensitive, but more speciﬁc, high-risk features such as
spotty calciﬁcation and napkin ring sign (3) would
have led to better prediction of ACS.
Secondly, the assessment of plaque volume, which
has been the strongest independent predictor of long-
term ACS (4), was not reported in this study. Instead
of deﬁning plaque progression using quantitative
analysis of plaque volume as is standardly done in
serial intravascular ultrasound studies, plaque pro-
gression was deﬁned as either an increase in stenosis
by at least 1 grade or an increase in the remodeling
index in this study. In addition, low-attenuation
J A C C V O L . 6 7 , N O . 4 , 2 0 1 6 Letters
F E B R U A R Y 2 , 2 0 1 6 : 4 5 5 – 6 1
459plaque volume, which had an area under the curve of
0.84 for predicting ACS, was not reported in this
study (2). This is of particular interest considering
recent studies that have demonstrated that low-
attenuated plaque burden improves determination
of functionally signiﬁcant stenosis by fractional ﬂow
reserve (5). It would have been of signiﬁcant interest
if quantitative plaque analysis was incorporated in
this study.
Lastly, the indication for 122 (49%) of patients to
serial CTA was for follow-up after percutaneous
coronary intervention. Could the authors clarify
whether this was performed for a clinical or research
indication?*Dennis T.L. Wong, MBBS (Hons)
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lesions. Radiology 2015;276:408–15.REPLY: Plaque Characterization by Coronary
Computed Tomography Angiography and
Association With Acute Coronary SyndromeWe thank Dr. Wong for the interest in our study (1)
and excellent suggestions. In our initial study
wherein we compared the culprit lesion of acute
coronary syndrome (ACS) with the target lesions in
stable angina (2), positive remodeling (PR), low-
attenuation plaques (LAP), and spotty calciﬁcationcharacterized the fateful plaques associated with
an acute coronary event. In our subsequent study (3),
we reported that PR and LAP plaques predicted
higher likelihood of acute coronary events during a
short-term follow up of 2 years. In the latter paper,
we also analyzed the relationship between spotty
calciﬁcation and acute coronary events; even though
the presence of spotty calciﬁcation was 2-fold higher
in the eventful compared with uneventful plaques,
the difference was statistically not signiﬁcant. On
the basis of this study, we deﬁned high-risk plaque
(HRP) as the 2-feature or 1-feature positive plaques
with PR and/or LAP in the latest study (1). In addition
to the higher likelihood of events arising from
HRP, we also observed that the period between the
computed tomography (CT) angiography and
the cardiac event associated with HRP was signiﬁ-
cantly shorter than the event arising from non-HRP
(1.7  1.8 vs. 3.4  2.4 years, p ¼ 0.0005). We agree
with Dr. Wong that the plaque volume, LAP volume,
and LAP area/plaque area as obtained in the intra-
vascular ultrasound studies (4) and as presented in
our previous study (3) should be included in CT
angiographic assessment. However, in our unpub-
lished experience, we have encountered napkin ring
sign (5) rather infrequently.
In the serial CT angiographic study, 122 patients
after percutaneous coronary intervention were eval-
uated for clinical indications such as the recurrence of
chest pain symptoms, or follow-up per discretion of
the physician. We excluded all the patients from
serial assessment who had sustained a cardiac event
before second CT angiogram was undertaken.Sadako Motoyama, MD, PhD*
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